HBIO
Harvard Bioscience Inc.
Company Overview
| Mkt Cap | $17.81M | Price | $0.52 |
| Volume | 17.00M | Change | -18.00% |
| P/E Ratio | -1.4 | Open | $0.56 |
| Revenue | $94.1M | Prev Close | $0.63 |
| Net Income | $-12.4M | 52W Range | $0.28 - $2.82 |
| Div Yield | N/A | Target | $2.00 |
| Overall | 53 | Value | 60 |
| Quality | 34 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyHarvard Bioscience Inc. (HBIO) is a leading Healthcare company in the Medical Instruments & Supplies industry, currently trading at $0.52 with a market capitalization of $17.81 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows HBIO with a volume of 17.00 million shares. The stock opened down 11.90% from yesterday's close of $0.63. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $NA.
HBIO demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including PKI, BRKR, A, TMO, JNJ.
Key investment considerations for HBIO include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 287.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 03:38 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HBIO | $0.52 | -18.0% | 17.00M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |